US Patent Issued to Amalive on Aug. 4 for "Dosages and uses of ornithine phenylacetate for treating hyperammonemia" (New York, California, Illinois, New Jersey, Massachusetts, Pennsylvania, Virginia Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,317, issued on Aug. 4, was assigned to Amalive Ltd. (Cambridge, Great Britain).

"Dosages and uses of ornithine phenylacetate for treating hyperammonemia" was invented by Xiaofeng Wang Rears (Boston), Jack Tseng (New York), Carmen Mak (Hampton, N.J.), Nagaraju Poola (Belle Mead, N.J.), Regis Vilchez (Chicago), Aniruddha Potnis (King of Prussia, Pa.), Susan VanMeter (Ashburn, Va.) and Jan Stange (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver d...